Related references
Note: Only part of the references are listed.Niacin activates the G protein estrogen receptor (GPER)-mediated signalling
Maria Francesca Santolla et al.
CELLULAR SIGNALLING (2014)
Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells
A. A. Amaro et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Contributions of Academic Laboratories to the Discovery and Development of Chemical Biology Tools
Donna M. Huryn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells
A. Chimento et al.
CELL DEATH & DISEASE (2013)
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
R. Lappano et al.
CURRENT CANCER DRUG TARGETS (2012)
Recent Advances in the Rationale Design of GPER Ligands
C. Rosano et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30
Ritwik Burai et al.
PLOS ONE (2012)
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells
Rosamaria Lappano et al.
BREAST CANCER RESEARCH (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
Megan K. Dennis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
The Cholesterol Metabolite 25-Hydroxycholesterol Activates Estrogen Receptor α-Mediated Signaling in Cancer Cells and in Cardiomyocytes
Rosamaria Lappano et al.
PLOS ONE (2011)
The unfolding stories of GPR30, a new membrane-bound estrogen receptor
Marcello Maggiolini et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30
Jeffrey B. Arterburn et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Estrogen-Related Cancer Microenvironment of Breast Carcinoma
Yuri Yamaguchi et al.
ENDOCRINE JOURNAL (2009)
Chronic Treatment with the G Protein-Coupled Receptor 30 Agonist G-1 Decreases Blood Pressure in Ovariectomized mRen2.Lewis Rats
Sarah Hoffmann Lindsey et al.
ENDOCRINOLOGY (2009)
Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats
R. Hammond et al.
HORMONES AND BEHAVIOR (2009)
Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis
Eric Blasko et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Mechanisms of estrogen signaling and gene expression via GPR30
Eric R. Prossnitz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
In vivo effects of a GPR30 antagonist
Megan K. Dennis et al.
NATURE CHEMICAL BIOLOGY (2009)
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Girieca Lorusso et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
The ins and outs of GPR30: A transmembrane estrogen receptor
Eric R. Prossnitz et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa et al.
NATURE CHEMICAL BIOLOGY (2006)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tumor-stroma interactions
NA Bhowmick et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Share Paper
